HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads

Frontiers in Microbiology

Volumn 6, Issue OCT, 2015, Pages

  Borgmann, Kathleen ^a   Ghorpade, Anuja ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Astroglia; HIV; Methamphetamine; Neurocognitive impairment; Neuroinflammation

Indexed keywords

GLYCOPROTEIN GP 120; METHAMPHETAMINE; NEF PROTEIN; PEPTIDES AND PROTEINS; TRACE AMINE ASSOCIATED RECEPTOR 1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ASTROCYTE; BLOOD BRAIN BARRIER; DOWN REGULATION; DRUG ABUSE; EXCITOTOXICITY; GLIOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROGLIA; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS VIRULENCE;

EID: 84946841193     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01143     Document Type: Review

References (443)

1. Abdul Muneer, P. M., Alikunju, S., Szlachetka, A. M., and Haorah, J. (2011). Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine. PLoS ONE 6:e19258. doi: 10.1371/journal.pone.0019258
2. Abramov, A. Y., Canevari, L., and Duchen, M. R. (2003). Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J. Neurosci. 23, 5088-5095.
3. Abudara, V., Roux, L., Dallérac, G., Matias, I., Dulong, J., Mothet, J. P., et al. (2015). Activated microglia impairs neuroglial interaction by opening Cx43 hemichannels in hippocampal astrocytes. Glia 63, 795-811. doi: 10.1002/glia.22785
4. Acharjee, S., Branton, W. G., Vivithanaporn, P., Maingat, F., Paul, A. M., Dickie, P., et al. (2014). HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors. Brain Behav. Immun. 40, 74-84. doi: 10.1016/j.bbi.2014.02.016
5. Achat-Mendes, C., Lynch, L. J., Sullivan, K. A., Vallender, E. J., and Miller, G. M. (2012). Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1. Pharmacol. Biochem. Behav. 101, 201-207. doi: 10.1016/j.pbb.2011.10.025
6. Agostoni, C., Bresson, J.-L, Fairweather-Tait, S., Flynn, A., Golly, I., Korhonen, H., et al. (2010). Scientific Opinion on the substantiation of health claims related to various food(s)/food constituent(s) and protection of cells from premature aging, antioxidant activity, antioxidant content and antioxidant properties, and protection of DNA, proteins and lipids from oxidative damage pursuant to Article 13(1) of Regulation (EC) No 1924/2006. Eur. Food Saf. Authority J. 8, 63. doi: 10.2903/j.efsa.2010.1489
7. Aguirre-Rueda, D., Guerra-Ojeda, S., Aldasoro, M., Iradi, A., Obrador, E., Mauricio, M. D., et al. (2015). WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid beta1-42 effects on astrocytes in primary culture. PLoS ONE 10:e0122843. doi: 10.1371/journal.pone.0122843
8. Akay, C., Cooper, M., Odeleye, A., Jensen, B. K., White, M. G., Vassoler, F., et al. (2014). Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J. Neurovirol. 20, 39-53. doi: 10.1007/s13365-013-0227-1
9. Allison, A. C., Cacabelos, R., Lombardi, V. R., Alvarez, X. A., and Vigo, C. (2001). Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341-1357. doi: 10.1016/S0278-5846(01)00192-0
10. Allritz, C., Bette, S., Figiel, M., and Engele, J. (2010). Comparative structural and functional analysis of the GLT-1/EAAT-2 promoter from man and rat. J. Neurosci. Res. 88, 1234-1241. doi: 10.1002/jnr.22303
11. Alvarez, J. I., Dodelet-Devillers, A., Kebir, H., Ifergan, I., Fabre, P. J., Terouz, S., et al. (2011). The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334, 1727-1731. doi: 10.1126/science.1206936
12. Amara, A., Gall, S. L., Schwartz, O., Salamero, J., Montes, M., Loetscher, P., et al. (1997). HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186, 139-146.
13. Ambrosini, E., Columba-Cabezas, S., Serafini, B., Muscella, A., and Aloisi, F. (2003). Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41, 290-300. doi: 10.1002/glia.10193
14. Ambrosini, E., Remoli, M. E., Giacomini, E., Rosicarelli, B., Serafini, B., Lande, R., et al. (2005). Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 64, 706-715. doi: 10.1097/01.jnen.0000173893.01929.fc
15. Anggadiredja, K., Nakamichi, M., Hiranita, T., Tanaka, H., Shoyama, Y., Watanabe, S., et al. (2004). Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology 29, 1470-1478. doi: 10.1038/sj.npp.1300454
16. Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., et al. (1995). Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
17. Asensio, V. C., Maier, J., Milner, R., Boztug, K., Kincaid, C., Moulard, M., et al. (2001). Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J. Virol. 75, 7067-7077. doi: 10.1128/JVI.75.15.7067-7077.2001
18. Ashutosh, Chao, C., Borgmann, K., Brew, K., and Ghorpade, A. (2012). Tissue inhibitor of metalloproteinases-1 protects human neurons from staurosporine and HIV-1-induced apoptosis: mechanisms and relevance to HIV-1-associated dementia. Cell Death Dis. 3, e332. doi: 10.1038/cddis.2012.54
19. Ashutosh, Kou, W., Cotter, R., Borgmann, K., Wu, L., Persidsky, R., et al. (2011). CXCL8 protects human neurons from amyloid-beta-induced neurotoxicity: relevance to Alzheimer's disease. Biochem. Biophys. Res. Commun. 412, 565-571. doi: 10.1016/j.bbrc.2011.07.127
20. Atluri, V. S., Hidalgo, M., Samikkannu, T., Kurapati, K. R., Jayant, R. D., Sagar, V., et al. (2015). Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front. Cell. Neurosci. 9:212. doi: 10.3389/fncel.2015.00212
21. Azevedo, F. A., Carvalho, L. R., Grinberg, L. T., Farfel, J. M., Ferretti, R. E., Leite, R. E., et al. (2009). Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 513, 532-541. doi: 10.1002/cne.21974
22. Babusyte, A., Kotthoff, M., Fiedler, J., and Krautwurst, D. (2013). Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2. J. Leukoc. Biol. 93, 387-394. doi: 10.1189/jlb.0912433
23. Badowski, M., and Pandit, N. S. (2014). Pharmacologic management of human immunodeficiency virus wasting syndrome. Pharmacotherapy 34, 868-881. doi: 10.1002/phar.1431
24. Bajetto, A., Barbero, S., Bonavia, R., Piccioli, P., Pirani, P., Florio, T., et al. (2001). Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J. Neurochem. 77, 1226-1236.
25. Bajetto, A., Bonavia, R., Barbero, S., Piccioli, P., Costa, A., Florio, T., et al. (1999). Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 73, 2348-2357. doi: 10.1046/j.1471-4159.2001.00350.x
26. Banerjee, A., Zhang, X., Manda, K. R., Banks, W. A., and Ercal, N. (2010). HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Free Radic. Biol. Med. 48, 1388-1398. doi: 10.1016/j.freeradbiomed.2010.02.023
27. Banerjee, S., Walseth, T. F., Borgmann, K., Wu, L., Bidasee, K. R., Kannan, M. S., et al. (2008). CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia. J. Neuroimmune Pharmacol. 3, 154-164. doi: 10.1007/s11481-008-9105-7
28. Batlle, M., Ferri, L., Andrade, C., Ortega, F. J., Vidal-Taboada, J. M., Pugliese, M., et al. (2015). Astroglia-microglia cross talk during neurodegeneration in the rat hippocampus. Biomed Res. Int. 2015:102419. doi: 10.1155/2015/102419
29. Baumruker, T., Billich, A., and Brinkmann, V. (2007). FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis. Expert Opin. Investig. Drugs 16, 283-289. doi: 10.1517/13543784.16.3.283
30. Benos, D. J., McPherson, S., Hahn, B. H., Chaikin, M. A., and Benveniste, E. N. (1994). Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes. J. Biol. Chem. 269, 13811-13816.
31. Beyer, M., Gimsa, U., Eyüpoglu, I. Y., Hailer, N. P., and Nitsch, R. (2000). Phagocytosis of neuronal or glial debris by microglial cells: upregulation of MHC class II expression and multinuclear giant cell formation in vitro. Glia 31, 262-266. doi: 10.1002/1098-1136(200009)31:3<262::AID-GLIA70>3.0.CO;2-2
32. Blanco, A., Alvarez, S., Fresno, M., and Muñoz-Fernández, M. A. (2008). Extracellular HIV-Tat induces cyclooxygenase-2 in glial cells through activation of nuclear factor of activated T cells. J. Immunol. 180, 530-540. doi: 10.4049/jimmunol.180.1.530
33. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., et al. (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833. doi: 10.1038/382829a0
34. Block, M. L., and Hong, J. S. (2005). Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76, 77-98. doi: 10.1016/j.pneurobio.2005.06.004
35. Bolick, D. T., Srinivasan, S., Kim, K. W., Hatley, M. E., Clemens, J. J., Whetzel, A., et al. (2005). Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler. Thromb. Vasc. Biol. 25, 976-981. doi: 10.1161/01.ATV.0000162171.30089.f6
36. Boridy, S., Soliman, G. M., and Maysinger, D. (2012). Modulation of inflammatory signaling and cytokine release from microglia by celastrol incorporated into dendrimer nanocarriers. Nanomedicine (Lond.) 7, 1149-1165. doi: 10.2217/nnm.12.16
37. Borjabad, A., Brooks, A. I., and Volsky, D. J. (2010). Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J. Neuroimmune Pharmacol. 5, 44-62. doi: 10.1007/s11481-009-9167-1
38. Boutet, A., Salim, H., Taoufik, Y., Lledo, P. M., Vincent, J. D., Delfraissy, J. F., et al. (2001). Isolated human astrocytes are not susceptible to infection by M-and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4. Glia 34, 165-177. doi: 10.1002/glia.1051
39. Boztug, K., Carson, M. J., Pham-Mitchell, N., Asensio, V. C., Demartino, J., and Campbell, I. L. (2002). Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J. Immunol. 169, 1505-1515. doi: 10.4049/jimmunol.169.3.1505
40. Brahmachari, S., Fung, Y. K., and Pahan, K. (2006). Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci. 26, 4930-4939. doi: 10.1523/JNEUROSCI.5480-05.2006
41. Brahmachari, S., Jana, A., and Pahan, K. (2009). Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J. Immunol. 183, 5917-5927. doi: 10.4049/jimmunol.0803336
42. Brandmann, M., Tulpule, K., Schmidt, M. M., and Dringen, R. (2012). The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrp1-mediated GSH export from cultured brain astrocytes. J. Neurochem. 120, 78-92. doi: 10.1111/j.1471-4159.2011.07544.x
43. Brew, B. J., Gray, L., Lewin, S., and Churchill, M. (2013). Is specific HIV eradication from the brain possible or needed? Expert Opin. Biol. Ther. 13, 403-409. doi: 10.1517/14712598.2013.748029
44. Brew, K., Dinakarpandian, D., and Nagase, H. (2000). Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477, 267-283. doi: 10.1016/S0167-4838(99)00279-4
45. Brosnan, C. F., and Raine, C. S. (2013). The astrocyte in multiple sclerosis revisited. Glia 61, 453-465. doi: 10.1002/glia.22443
46. Bruder, C., Hagleitner, M., Darlington, G., Mohsenipour, I., Würzner, R., Höllmüller, I., et al. (2004). HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity. Mol. Immunol. 40, 949-961.
47. Burdo, T. H., Lackner, A., and Williams, K. C. (2013). Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol. Rev. 254, 102-113. doi: 10.1111/imr.12068
48. Burkert, K., Moodley, K., Angel, C. E., Brooks, A., and Graham, E. S. (2012). Detailed analysis of inflammatory and neuromodulatory cytokine secretion from human NT2 astrocytes using multiplex bead array. Neurochem. Int. 60, 573-580. doi: 10.1016/j.neuint.2011.09.002
49. Butt, A. M. (2011). ATP: a ubiquitous gliotransmitter integrating neuron-glial networks. Semin. Cell Dev. Biol. 22, 205-213. doi: 10.1016/j.semcdb.2011.02.023
50. Cadet, J. L., and Krasnova, I. N. (2007). Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation. Neurotox. Res. 12, 181-204. doi: 10.1007/BF03033915
51. Cadet, J. L., and Krasnova, I. N. (2009). Molecular bases of methamphetamine-induced neurodegeneration. Int. Rev. Neurobiol. 88, 101-119. doi: 10.1016/S0074-7742(09)88005-7
52. Cadet, J. L., Sheng, P., Ali, S., Rothman, R., Carlson, E., and Epstein, C. (1994). Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62, 380-383.
53. Cai, N. S., and Cadet, J. L. (2008). The combination of methamphetamine and of the HIV protein, Tat, induces death of the human neuroblastoma cell line, SH-SY5Y. Synapse 62, 551-552. doi: 10.1002/syn.20512
54. Camacho, A., and Massieu, L. (2006). Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch. Med. Res. 37, 11-18. doi: 10.1016/j.arcmed.2005.05.014
55. Canki, M., Thai, J. N., Chao, W., Ghorpade, A., Potash, M. J., and Volsky, D. J. (2001). Highly productive infection with pseudotyped human immunodeficiency virus type 1 (hiv-1) indicates no intracellular restrictions to hiv-1 replication in primary human astrocytes. J. Virol. 75, 7925-7933. doi: 10.1128/JVI.75.17.7925-7933.2001
56. Carroll-Anzinger, D., Kumar, A., Adarichev, V., Kashanchi, F., and Al-Harthi, L. (2007). Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway. J. Virol. 81, 5864-5871. doi: 10.1128/JVI.02234-06
57. Carvallo, L., Lopez, L., Che, F. Y., Lim, J., Eugenin, E. A., Williams, D. W., et al. (2015). Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes. J. Immunol. 194, 3246-3258. doi: 10.4049/jimmunol.1302647
58. Casano, A. M., and Peri, F. (2015). Microglia: multitasking specialists of the brain. Dev. Cell 32, 469-477. doi: 10.1016/j.devcel.2015.01.018
59. Cass, W. A., Harned, M. E., Peters, L. E., Nath, A., and Maragos, W. F. (2003). HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Res. 984, 133-142. doi: 10.1016/S0006-8993(03)03122-6
60. Castelli, M. P., Madeddu, C., Casti, A., Casu, A., Casti, P., Scherma, M., et al. (2014). Delta9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity. PLoS ONE 9:e98079. doi: 10.1371/journal.pone.0098079
61. Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., et al. (2008). Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9, 137-145. doi: 10.1038/ni1551
62. Cekanaviciute, E., Dietrich, H. K., Axtell, R. C., Williams, A. M., Egusquiza, R., Wai, K. M., et al. (2014). Astrocytic TGF-beta signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. J. Immunol. 193, 139-149. doi: 10.4049/jimmunol.1303284
63. Cen, P., Ye, L., Su, Q. J., Wang, X., Li, J. L., Lin, X. Q., et al. (2013). Methamphetamine inhibits Toll-like receptor 9-mediated anti-HIV activity in macrophages. AIDS Res. Hum. Retroviruses 29, 1129-1137. doi: 10.1089/AID.2012.0264
64. Chao, C., and Ghorpade, A. (2009). Production and roles of glial tissue inhibitor of metalloproteinases-1 in human immunodeficiency virus-1-associated dementia neuroinflammation: a Review. Am. J. Infect. Dis. 5, 314-320. doi: 10.3844/ajidsp.2009.307.313
65. Chauhan, A. (2014). Unperturbed posttranscriptional regulatory Rev protein function and HIV-1 replication in astrocytes. PLoS ONE 9:e106910. doi: 10.1371/journal.pone.0106910
66. Chauhan, A. (2015). Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent. Microbes Infect. 17, 651-659. doi: 10.1016/j.micinf.2015.05.006
67. Chauhan, A., Tikoo, A., Patel, J., and Abdullah, A. M. (2014). HIV-1 endocytosis in astrocytes: a kiss of death or survival of the fittest? Neurosci. Res. 88, 16-22. doi: 10.1016/j.neures.2014.08.013
68. Chen, L. W., Yung, K. L., and Chan, Y. S. (2005). Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease. Curr. Drug Targets 6, 821-833. doi: 10.2174/138945005774574506
69. Chiu, V. M., and Schenk, J. O. (2012). Mechanism of action of methamphetamine within the catecholamine and serotonin areas of the central nervous system. Curr. Drug Abuse Rev. 5, 227-242. doi: 10.2174/1874473711205030227
70. Chiueh, C. C., and Rauhala, P. (1999). The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic. Res. 31, 641-650.
71. Choi, S. S., Lee, H. J., Lim, I., Satoh, J., and Kim, S. U. (2014). Human astrocytes: secretome profiles of cytokines and chemokines. PLoS ONE 9:e92325. doi: 10.1371/journal.pone.0092325
72. Chuang, J. Y., Chang, P. C., Shen, Y. C., Lin, C., Tsai, C. F., Chen, J. H., et al. (2014). Regulatory effects of fisetin on microglial activation. Molecules 19, 8820-8839. doi: 10.3390/molecules19078820
73. Chui, R., and Dorovini-Zis, K. (2010). Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide. J. Neuroinflammation 7:1. doi: 10.1186/1742-2094-7-1
74. Churchill, M., and Nath, A. (2013). Where does HIV hide? A focus on the central nervous system. Curr. Opin. HIV AIDS 8, 165-169. doi: 10.1097/COH.0b013e32835fc601
75. Cisneros, I. E., and Ghorpade, A. (2012). HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS. Curr. HIV Res. 10, 392-406. doi: 10.2174/157016212802138832
76. Cisneros, I. E., and Ghorpade, A. (2014). Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes. Neuropharmacology 85, 499-507. doi: 10.1016/j.neuropharm.2014.06.011
77. Clark, R. T., Nance, J. P., Noor, S., and Wilson, E. H. (2011). T-cell production of matrix metalloproteinases and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain. ASN Neuro 3:e00049. doi: 10.1042/AN20100027
78. Cobb, C. A., and Cole, M. P. (2015). Oxidative and nitrative stress in neurodegeneration. Neurobiol. Dis. doi: 10.1016/j.nbd.2015.04.020. [Epub ahead of print].
79. Coelho-Santos, V., Leitão, R. A., Cardoso, F. L., Palmela, I., Rito, M., Barbosa, M., et al. (2015). The TNF-alpha/NF-kappaB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 35, 1260-1271. doi: 10.1038/jcbfm.2015.59
80. Colombo, E., Di Dario, M., Capitolo, E., Chaabane, L., Newcombe, J., Martino, G., et al. (2014). Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide. Ann. Neurol. 76, 325-337. doi: 10.1002/ana.24217
81. Coltart, I., Tranah, T. H., and Shawcross, D. L. (2013). Inflammation and hepatic encephalopathy. Arch. Biochem. Biophys. 536, 189-196. doi: 10.1016/j.abb.2013.03.016
82. Columba-Cabezas, S., Serafini, B., Ambrosini, E., and Aloisi, F. (2003). Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol. 13, 38-51. doi: 10.1111/j.1750-3639.2003.tb00005.x
83. Constantinescu, C. S., Frei, K., Wysocka, M., Trinchieri, G., Malipiero, U., Rostami, A., et al. (1996). Astrocytes and microglia produce interleukin-12 p40. Ann. N.Y. Acad. Sci. 795, 328-333.
84. Constantinescu, C. S., Tani, M., Ransohoff, R. M., Wysocka, M., Hilliard, B., Fujioka, T., et al. (2005). Astrocytes as antigen-presenting cells: expression of IL-12/IL-23. J. Neurochem. 95, 331-340. doi: 10.1111/j.1471-4159.2005.03368.x
85. Cooley, I. D., Chauhan, V. S., Donneyz, M. A., and Marriott, I. (2014). Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member. Glia 62, 818-828. doi: 10.1002/glia.22644
86. Cossarizza, A., Troiano, L., and Mussini, C. (2002). Mitochondria and HIV infection: the first decade. J. Biol. Regul. Homeost. Agents 16, 18-24.
87. Cota, M., Kleinschmidt, A., Ceccherini-Silberstein, F., Aloisi, F., Mengozzi, M., Mantovani, A., et al. (2000). Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. J. Neurovirol. 6, 75-83. doi: 10.3109/13550280009006384
88. Coughlan, C. M., McManus, C. M., Sharron, M., Gao, Z., Murphy, D., Jaffer, S., et al. (2000). Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97, 591-600. doi: 10.1016/S0306-4522(00)00024-5
89. Coyle-Rink, J., Sweet, T., Abraham, S., Sawaya, B., Batuman, O., Khalili, K., et al. (2002). Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes. Virology 299, 240-247. doi: 10.1006/viro.2002.1439
90. Cregg, J. M., DePaul, M. A., Filous, A. R., Lang, B. T., Tran, A., and Silver, J. (2014). Functional regeneration beyond the glial scar. Exp. Neurol. 253, 197-207. doi: 10.1016/j.expneurol.2013.12.024
91. Croitoru-Lamoury, J., Guillemin, G. J., Boussin, F. D., Mognetti, B., Gigout, L. I., Chéret, A., et al. (2003). Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 41, 354-370. doi: 10.1002/glia.10181
92. Cupp, C., Taylor, J. P., Khalili, K., and Amini, S. (1993). Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8, 2231-2236.
93. da Cunha, A., Jackson, R. W., and Vitkovic, L. (1995). HIV-1 non-specifically stimulates production of transforming growth factor-beta 1 transfer in primary astrocytes. J. Neuroimmunol. 60, 125-133.
94. da Cunha, A., and Vitkovic, L. (1992). Transforming growth factor-beta 1 (TGF-beta 1) expression and regulation in rat cortical astrocytes. J. Neuroimmunol. 36, 157-169.
95. da Fonseca, A. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., et al. (2014). The impact of microglial activation on blood-brain barrier in brain diseases. Front. Cell. Neurosci. 8:362. doi: 10.3389/fncel.2014.00362
96. de Jong, B. C., Prentiss, D., McFarland, W., Machekano, R., and Israelski, D. M. (2005). Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J. Acquir. Immune Defic. Syndr. 38, 43-46. doi: 10.1097/00126334-200501010-00008
97. Desplats, P., Dumaop, W., Cronin, P., Gianella, S., Woods, S., Letendre, S., et al. (2014). Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PLoS ONE 9:e102555. doi: 10.1371/journal.pone.0102555
98. Devinsky, O., Vezzani, A., Najjar, S., De Lanerolle, N. C., and Rogawski, M. A. (2013). Glia and epilepsy: excitability and inflammation. Trends Neurosci. 36, 174-184. doi: 10.1016/j.tins.2012.11.008
99. Dhar, A., Gardner, J., Borgmann, K., Wu, L., and Ghorpade, A. (2006). Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation. J. Neurosci. Res. 83, 1271-1280. doi: 10.1002/jnr.20787
100. Díaz, L., Martínez-Bonet, M., Sánchez, J., Fernández-Pineda, A., Jiménez, J. L., Muñoz, E., et al. (2015). Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-kB-dependent mechanism. Sci. Rep. 5:12442. doi: 10.1038/srep12442
101. Dietrich, J. B. (2009). Alteration of blood-brain barrier function by methamphetamine and cocaine. Cell Tissue Res. 336, 385-392. doi: 10.1007/s00441-009-0777-y
102. Dobbing, J., and Sands, J. (1973). Quantitative growth and development of human brain. Arch. Dis. Child. 48, 757-767.
103. Duffy, S., and MacVicar, B. A. (1996). In vitro ischemia promotes calcium influx and intracellular calcium release in hippocampal astrocytes. J. Neurosci. 16, 71-81.
104. Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., and Luster, A. D. (2002). IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168, 3195-3204. doi: 10.4049/jimmunol.168.7.3195
105. Dujmovic, I., Mangano, K., Pekmezovic, T., Quattrocchi, C., Mesaros, S., Stojsavljevic, N., et al. (2009). The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy. J. Neuroimmunol. 207, 101-106. doi: 10.1016/j.jneuroim.2008.11.004
106. Elahy, M., Jackaman, C., Mamo, J. C., Lam, V., Dhaliwal, S. S., Giles, C., et al. (2015). Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun. Ageing 12, 2. doi: 10.1186/s12979-015-0029-9
107. Elain, G., Jeanneau, K., Rutkowska, A., Mir, A. K., and Dev, K. K. (2014). The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes. Glia 62, 725-735. doi: 10.1002/glia.22637
108. El-Hage, N., Podhaizer, E. M., Sturgill, J., and Hauser, K. F. (2011). Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. Immunol. Invest. 40, 498-522. doi: 10.3109/08820139.2011.561904
109. Elmore, M. R., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., et al. (2014). Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82, 380-397. doi: 10.1016/j.neuron.2014.02.040
110. Endo, F., Komine, O., Fujimori-Tonou, N., Katsuno, M., Jin, S., Watanabe, S., et al. (2015). Astrocyte-derived TGF-beta1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Rep. 11, 592-604. doi: 10.1016/j.celrep.2015.03.053
111. Erdmann, N., Tian, C., Huang, Y., Zhao, J., Herek, S., Curthoys, N., et al. (2009). In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage. J. Neurochem. 109, 551-561. doi: 10.1111/j.1471-4159.2009.05989.x
112. Erdmann, N. B., Whitney, N. P., and Zheng, J. (2006). Potentiation of excitotoxicity in HIV-1 associated dementia and the significance of glutaminase. Clin. Neurosci. Res. 6, 315-328. doi: 10.1016/j.cnr.2006.09.009
113. Ernst, T., Chang, L., Leonido-Yee, M., and Speck, O. (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54, 1344-1349. doi: 10.1212/WNL.54.6.1344
114. Espey, M. G., Basile, A. S., Heaton, R. K., and Ellis, R. J. (2002). Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 58, 1439. author reply 1439-1440. doi: 10.1212/wnl.58.9.1439
115. Espinoza, S., Lignani, G., Caffino, L., Maggi, S., Sukhanov, I., Leo, D., et al. (2015). TAAR1 modulates cortical glutamate NMDA receptor function. Neuropsychopharmacology 40, 2217-2227. doi: 10.1038/npp.2015.65
116. Eugenin, E. A., and Berman, J. W. (2013). Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism. J. Neurochem. 127, 644-651. doi: 10.1111/jnc.12443
117. Eugenin, E. A., Clements, J. E., Zink, M. C., and Berman, J. W. (2011). Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J. Neurosci. 31, 9456-9465. doi: 10.1523/JNEUROSCI.1460-11.2011
118. Evans, M. C., Couch, Y., Sibson, N., and Turner, M. R. (2013). Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 53, 34-41. doi: 10.1016/j.mcn.2012.10.008
119. Falconer, K., Askarieh, G., Weis, N., Hellstrand, K., Alaeus, A., and Lagging, M. (2010). IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV. Scand. J. Infect. Dis. 42, 896-901. doi: 10.3109/00365548.2010.498019
120. Falsig, J., Latta, M., and Leist, M. (2004). Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J. Neurochem. 88, 181-193. doi: 10.1111/j.1471-4159.2004.02144.x
121. Fan, Y., Timani, K. A., and He, J. J. (2015). STAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic protein. Curr. HIV Res. 13, 55-63. doi: 10.2174/1570162x13666150121115804
122. Feliú, A., Moreno-Martet, M., Mecha, M., Carrillo-Salinas, F. J., De Lago, E., Fernàndez-Ruiz, J., et al. (2015). A Sativex((R))-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. Br. J. Pharmacol. 172, 3579-3595. doi: 10.1111/bph.13159
123. Ferrarese, C., Aliprandi, A., Tremolizzo, L., Stanzani, L., De Micheli, A., Dolara, A., et al. (2001). Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57, 671-675. doi: 10.1212/WNL.57.4.671
124. Ferrucci, A., Nonnemacher, M. R., and Wigdahl, B. (2013). Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival. J. Neurovirol. 19, 239-253. doi: 10.1007/s13365-013-0170-1
125. Fiebich, B. L., Schleicher, S., Spleiss, O., Czygan, M., and Hüll, M. (2001). Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J. Neurochem. 79, 950-958. doi: 10.1046/j.1471-4159.2001.00652.x
126. Fields, J., Cisneros, I. E., Borgmann, K., and Ghorpade, A. (2013). Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1beta-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression. PLoS ONE 8:e56891. doi: 10.1371/journal.pone.0056891
127. Fields, J., Gardner-Mercer, J., Borgmann, K., Clark, I., and Ghorpade, A. (2011). CCAAT/enhancer binding protein beta expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1. J. Neurochem. 118, 93-104. doi: 10.1111/j.1471-4159.2011.07203.x
128. Fields, J., and Ghorpade, A. (2012). C/EBPbeta regulates multiple IL-1beta-induced human astrocyte inflammatory genes. J. Neuroinflammation 9:177. doi: 10.1186/1742-2094-9-177
129. Fine, S. M., Angel, R. A., Perry, S. W., Epstein, L. G., Rothstein, J. D., Dewhurst, S., et al. (1996). Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 271, 15303-15306.
130. Fitting, S., Scoggins, K. L., Xu, R., Dever, S. M., Knapp, P. E., Dewey, W. L., et al. (2012). Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. Eur. J. Pharmacol. 689, 96-103. doi: 10.1016/j.ejphar.2012.05.029
131. Fitting, S., Zou, S., El-Hage, N., Suzuki, M., Paris, J. J., Schier, C. J., et al. (2014). Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca(2)(+)]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity. Curr. HIV Res. 12, 424-434. doi: 10.2174/1570162X1206150311161147
132. Flora, G., Lee, Y. W., Nath, A., Hennig, B., Maragos, W., and Toborek, M. (2003). Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp. Neurol. 179, 60-70. doi: 10.1006/exnr.2002.8048
133. Flora, G., Pu, H., Hennig, B., and Toborek, M. (2006). Cyclooxygenase-2 is involved in HIV-1 Tat-induced inflammatory responses in the brain. Neuromolecular Med. 8, 337-352. doi: 10.1385/NMM:8:3:337
134. Flynn, G., Maru, S., Loughlin, J., Romero, I. A., and Male, D. (2003). Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136, 84-93. doi: 10.1016/S0165-5728(03)00009-2
135. Frampton, M., Harvey, R. J., and Kirchner, V. (2003). Propentofylline for dementia. Cochrane Database Syst. Rev. CD002853. doi: 10.1002/14651858.CD002853
136. French, M. A., Cozzi-Lepri, A., Arduino, R. C., Johnson, M., Achhra, A. C., Landay, A., et al. (2015). Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial. AIDS 29, 847-851. doi: 10.1097/QAD.0000000000000618
137. Friend, D. M., and Keefe, K. A. (2013). Glial reactivity in resistance to methamphetamine-induced neurotoxicity. J. Neurochem. 125, 566-574. doi: 10.1111/jnc.12201
138. Gardner, J., Borgmann, K., Deshpande, M. S., Dhar, A., Wu, L., Persidsky, R., et al. (2006). Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases. J. Neurosci. Res. 83, 1281-1292. doi: 10.1002/jnr.20823
139. Gardner, J., and Ghorpade, A. (2003). Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 74, 801-806. doi: 10.1002/jnr.10835
140. Garlind, A., Brauner, A., Höjeberg, B., Basun, H., and Schultzberg, M. (1999). Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients. Brain Res. 826, 112-116.
141. Gavrilin, M. A., Mathes, L. E., and Podell, M. (2002). Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J. Neurovirol. 8, 240-249. doi: 10.1080/13550280290049660
142. Gelman, B. B. (2015). Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr. HIV/AIDS Rep. 12, 272-279. doi: 10.1007/s11904-015-0266-8
143. Gendelman, H. E. (2005). The Neurology of AIDS. Oxford; New York, NY: Oxford University Press.
144. Genis, P., Jett, M., Bernton, E. W., Boyle, T., Gelbard, H. A., Dzenko, K., et al. (1992). Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176, 1703-1718.
145. Ghorpade, A., Holter, S., Borgmann, K., Persidsky, R., and Wu, L. (2003). HIV-1 and IL-1beta regulate Fas ligand expression in human astrocytes through the NF-kappaB pathway. J. Neuroimmunol. 141, 141-149. doi: 10.1016/S0165-5728(03)00222-4
146. Giaume, C., Tabernero, A., and Medina, J. M. (1997). Metabolic trafficking through astrocytic gap junctions. Glia 21, 114-123.
147. Gil, L., Martínez, G., González, I., Tarinas, A., Alvarez, A., Giuliani, A., et al. (2003). Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol. Res. 47, 217-224. doi: 10.1016/S1043-6618(02)00320-1
148. Gill, A. J., Kovacsics, C. E., Cross, S. A., Vance, P. J., Kolson, L. L., Jordan-Sciutto, K. L., et al. (2014). Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J. Clin. Invest. 124, 4459-4472. doi: 10.1172/JCI72279
149. Gonçalves, J., Baptista, S., Martins, T., Milhazes, N., Borges, F., Ribeiro, C. F., et al. (2010). Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur. J. Neurosci. 31, 315-326. doi: 10.1111/j.1460-9568.2009.07059.x
150. Gonçalves, J., Martins, T., Ferreira, R., Milhazes, N., Borges, F., Ribeiro, C. F., et al. (2008). Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann. N.Y. Acad. Sci. 1139, 103-111. doi: 10.1196/annals.1432.043
151. Gorantla, S., Liu, J., Sneller, H., Dou, H., Holguin, A., Smith, L., et al. (2007). Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis. J. Immunol. 179, 4345-4356. doi: 10.4049/jimmunol.179.7.4345
152. Gorantla, S., Liu, J., Wang, T., Holguin, A., Sneller, H. M., Dou, H., et al. (2008). Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis. Glia 56, 223-232. doi: 10.1002/glia.20607
153. Gorry, P. R., Ong, C., Thorpe, J., Bannwarth, S., Thompson, K. A., Gatignol, A., et al. (2003). Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr. HIV Res. 1, 463-473. doi: 10.2174/1570162033485122
154. Granado, N., Lastres-Becker, I., Ares-Santos, S., Oliva, I., Martin, E., Cuadrado, A., et al. (2011). Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum. Glia 59, 1850-1863. doi: 10.1002/glia.21229
155. Gray, L. R., Turville, S. G., Hitchen, T. L., Cheng, W. J., Ellett, A. M., Salimi, H., et al. (2014). HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles. PLoS ONE 9:e90620. doi: 10.1371/journal.pone.0090620
156. Griffin, B. D., and Moynagh, P. N. (2006). Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells. J. Biol. Chem. 281, 10316-10326. doi: 10.1074/jbc.M509973200
157. Guillot, T. S., Shepherd, K. R., Richardson, J. R., Wang, M. Z., Li, Y., Emson, P. C., et al. (2008). Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis. J. Neurochem. 106, 2205-2217. doi: 10.1111/j.1471-4159.2008.05568.x
158. Gupta, S., Bousman, C. A., Chana, G., Cherner, M., Heaton, R. K., Deutsch, R., et al. (2011). Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings. J. Neurovirol. 17, 239-247. doi: 10.1007/s13365-011-0028-3
159. Häberle, J., Boddaert, N., Burlina, A., Chakrapani, A., Dixon, M., Huemer, M., et al. (2012). Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J. Rare Dis. 7:32. doi: 10.1186/1750-1172-7-32
160. Hamm, S., Dehouck, B., Kraus, J., Wolburg-Buchholz, K., Wolburg, H., Risau, W., et al. (2004). Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts. Cell Tissue Res. 315, 157-166. doi: 10.1007/s00441-003-0825-y
161. Han, J., Kesner, P., Metna-Laurent, M., Duan, T., Xu, L., Georges, F., et al. (2012). Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148, 1039-1050. doi: 10.1016/j.cell.2012.01.037
162. Harouse, J. M., Kunsch, C., Hartle, H. T., Laughlin, M. A., Hoxie, J. A., Wigdahl, B., et al. (1989). CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63, 2527-2533.
163. Harris, G. E., Dupuis, L., Mugford, G. J., Johnston, L., Haase, D., Page, G., et al. (2014). Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada. Can. J. Infect. Dis. Med. Microbiol. 25, e1-e7.
164. Hashioka, S., Klegeris, A., and McGeer, P. L. (2012). Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers. Neuropharmacology 63, 685-691. doi: 10.1016/j.neuropharm.2012.05.033
165. Haughey, N. J., Nath, A., Mattson, M. P., Slevin, J. T., and Geiger, J. D. (2001). HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J. Neurochem. 78, 457-467. doi: 10.1046/j.1471-4159.2001.00396.x
166. Hauwel, M., Furon, E., Canova, C., Griffiths, M., Neal, J., and Gasque, P. (2005). Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res. Brain Res. Rev. 48, 220-233. doi: 10.1016/j.brainresrev.2004.12.012
167. Haydon, P. G. (2001). GLIA: listening and talking to the synapse. Nat. Rev. Neurosci. 2, 185-193. doi: 10.1038/35058528
168. Hebert, M. A., and O'Callaghan, J. P. (2000). Protein phosphorylation cascades associated with methamphetamine-induced glial activation. Ann. N.Y. Acad. Sci. 914, 238-262. doi: 10.1111/j.1749-6632.2000.tb05200.x
169. Hennessy, E., Griffin, E. W., and Cunningham, C. (2015). Astrocytes are primed by chronic neurodegeneration to produce exaggerated chemokine and cell infiltration responses to acute stimulation with the cytokines IL-1beta and TNF-alpha. J. Neurosci. 35, 8411-8422. doi: 10.1523/JNEUROSCI.2745-14.2015
170. Hermann, D. M., Peruzzotti-Jametti, L., Schlechter, J., Bernstock, J. D., Doeppner, T. R., and Pluchino, S. (2014). Neural precursor cells in the ischemic brain-integration, cellular crosstalk, and consequences for stroke recovery. Front. Cell. Neurosci. 8:291. doi: 10.3389/fncel.2014.00291
171. Hind, W. H., Tufarelli, C., Neophytou, M., Anderson, S. I., England, T. J., and O'sullivan, S. E. (2015). Endocannabinoids modulate human blood-brain barrier permeability in vitro. Br. J. Pharmacol. 172, 3015-3027. doi: 10.1111/bph.13106
172. Hirata, H., Ladenheim, B., Rothman, R. B., Epstein, C., and Cadet, J. L. (1995). Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677, 345-347.
173. Hoefer, M. M., Sanchez, A. B., Maung, R., de Rozieres, C. M., Catalan, I. C., Dowling, C. C., et al. (2015). Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system. Exp. Neurol. 263, 221-234. doi: 10.1016/j.expneurol.2014.09.010
174. Hori, K., Burd, P. R., Kutza, J., Weih, K. A., and Clouse, K. A. (1999). Human astrocytes inhibit HIV-1 expression in monocyte-derived macrophages by secreted factors. AIDS 13, 751-758.
175. Hozumi, H., Asanuma, M., Miyazaki, I., Fukuoka, S., Kikkawa, Y., Kimoto, N., et al. (2008). Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity. Toxicol. Lett. 177, 123-129. doi: 10.1016/j.toxlet.2008.01.005
176. Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., and Van Eldik, L. J. (1998). Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785, 195-206.
177. Hu, S., Sheng, W. S., and Rock, R. B. (2013). CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120. PLoS ONE 8:e77577. doi: 10.1371/journal.pone.0077577
178. Huang, S.-P. (2005). Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer. U.S. National Institutes of Health. Available online at: https://clinicaltrials.gov/ (September 12, 2005)
179. Huang, Y., Zhao, L., Jia, B., Wu, L., Li, Y., Curthoys, N., et al. (2011). Glutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: relevant to HIV-1-associated neurocognitive disorders. J. Neurosci. 31, 15195-15204. doi: 10.1523/JNEUROSCI.2051-11.2011
180. Hult, B., Chana, G., Masliah, E., and Everall, I. (2008). Neurobiology of HIV. Int. Rev. Psychiatry 20, 3-13. doi: 10.1080/09540260701862086
181. Hwang, J., Zheng, L. T., Ock, J., Lee, M. G., Kim, S. H., Lee, H. W., et al. (2008). Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 55, 826-834. doi: 10.1016/j.neuropharm.2008.06.045
182. Igelhorst, B. A., Niederkinkhaus, V., Karus, C., Lange, M. D., and Dietzel, I. D. (2015). Regulation of neuronal excitability by release of proteins from glial cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370:20140194. doi: 10.1098/rstb.2014.0194
183. In, S. W., Son, E. W., Rhee, D. K., and Pyo, S. (2005). Methamphetamine administration produces immunomodulation in mice. J. Toxicol. Environ. Health A 68, 2133-2145. doi: 10.1080/15287390500177156
184. Indo, H. P., Yen, H. C., Nakanishi, I., Matsumoto, K., Tamura, M., Nagano, Y., et al. (2015). A mitochondrial superoxide theory for oxidative stress diseases and aging. J. Clin. Biochem. Nutr. 56, 1-7. doi: 10.3164/jcbn.14-42
185. Itzhak, Y., and Ali, S. F. (1996). The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67, 1770-1773.
186. Itzhak, Y., Martin, J. L., and Ail, S. F. (2000). nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice. Neuroreport 11, 2943-2946. doi: 10.1097/00001756-200009110-00022
187. Iudicello, J. E., Morgan, E. E., Gongvatana, A., Letendre, S. L., Grant, I., Woods, S. P., et al. (2014). Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect? J. Neurovirol. 20, 85-98. doi: 10.1007/s13365-014-0233-y
188. Ivey, N. S., MacLean, A. G., and Lackner, A. A. (2009). Acquired immunodeficiency syndrome and the blood-brain barrier. J. Neurovirol. 15, 111-122. doi: 10.1080/13550280902769764
189. Jacobs, V. L., and De Leo, J. A. (2013). Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model. J. Neurooncol. 114, 33-42. doi: 10.1007/s11060-013-1158-7
190. Jacobs, V. L., Landry, R. P., Liu, Y., Romero-Sandoval, E. A., and De Leo, J. A. (2012). Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol. 14, 119-131. doi: 10.1093/neuonc/nor194
191. Jaiswal, M. K., Zech, W. D., Goos, M., Leutbecher, C., Ferri, A., Zippelius, A., et al. (2009). Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease. BMC Neurosci. 10:64. doi: 10.1186/1471-2202-10-64
192. Jean, Y. Y., Lercher, L. D., and Dreyfus, C. F. (2008). Glutamate elicits release of BDNF from basal forebrain astrocytes in a process dependent on metabotropic receptors and the PLC pathway. Neuron Glia Biol. 4, 35-42. doi: 10.1017/S1740925X09000052
193. Jha, M. K., and Suk, K. (2014). Management of glia-mediated neuroinflammation and related patents. Recent Pat. Inflamm. Allergy Drug Discov. 8, 118-124.
194. Jing, T., Wu, L., Borgmann, K., Surendran, S., Ghorpade, A., Liu, J., et al. (2010). Soluble factors from IL-1beta-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration. Biochem. Biophys. Res. Commun. 402, 241-246. doi: 10.1016/j.bbrc.2010.10.006
195. John, G. R., Lee, S. C., and Brosnan, C. F. (2003). Cytokines: powerful regulators of glial cell activation. Neuroscientist 9, 10-22. doi: 10.1177/1073858402239587
196. Jou, M. J. (2008). Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes. Adv. Drug Deliv. Rev. 60, 1512-1526. doi: 10.1016/j.addr.2008.06.004
197. Jung, H. W., Chung, Y. S., Kim, Y. S., and Park, Y. K. (2007). Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells. Exp. Mol. Med. 39, 715-721. doi: 10.1038/emm.2007.78
198. Kamat, P. K., Swarnkar, S., Rai, S., Kumar, V., and Tyagi, N. (2014). Astrocyte mediated MMP-9 activation in the synapse dysfunction: an implication in Alzheimer disease. Ther. Targets Neurol. Dis. 1:e243. doi: 10.14800/ttnd.243
199. Kandel, E. R., Schwartz, J. H., and Jessell, T. M. (2000). Principles of Neural Science. New York, NY: McGraw-Hill, Health Professions Division.
200. Kang, D. C., Su, Z. Z., Sarkar, D., Emdad, L., Volsky, D. J., and Fisher, P. B. (2005). Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353, 8-15. doi: 10.1016/j.gene.2005.04.006
201. Kaul, M., and Lipton, S. A. (1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A. 96, 8212-8216.
202. Kaushal, N., and Matsumoto, R. R. (2011). Role of sigma receptors in methamphetamine-induced neurotoxicity. Curr. Neuropharmacol. 9, 54-57. doi: 10.2174/157015911795016930
203. Kaushal, N., Robson, M. J., Rosen, A., McCurdy, C. R., and Matsumoto, R. R. (2014). Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro. Eur. J. Pharmacol. 724, 193-203. doi: 10.1016/j.ejphar.2013.12.039
204. Kaushal, N., Seminerio, M. J., Robson, M. J., McCurdy, C. R., and Matsumoto, R. R. (2013). Pharmacological evaluation of SN79, a sigma (sigma) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. Eur. Neuropsychopharmacol. 23, 960-971. doi: 10.1016/j.euroneuro.2012.08.005
205. Kaushal, N., Seminerio, M. J., Shaikh, J., Medina, M. A., Mesangeau, C., Wilson, L. L., et al. (2011). CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice. Neuropharmacology 61, 992-1000. doi: 10.1016/j.neuropharm.2011.06.028
206. Kielian, T. (2004). Immunopathogenesis of brain abscess. J. Neuroinflammation 1, 16. doi: 10.1186/1742-2094-1-16
207. Kim, M. O., Suh, H. S., Brosnan, C. F., and Lee, S. C. (2004). Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta. J. Neurochem. 90, 297-308. doi: 10.1111/j.1471-4159.2004.02487.x
208. Kita, T., Miyazaki, I., Asanuma, M., Takeshima, M., and Wagner, G. C. (2009). Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int. Rev. Neurobiol. 88, 43-64. doi: 10.1016/S0074-7742(09)88003-3
209. Kita, T., Wagner, G. C., and Nakashima, T. (2003). Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J. Pharmacol. Sci. 92, 178-195. doi: 10.1254/jphs.92.178
210. Kitanaka, J., Kitanaka, N., Hall, F. S., Uhl, G. R., Tanaka, K., Nishiyama, N., et al. (2012). Straub tail reaction in mice treated with sigma(1) receptor antagonist in combination with methamphetamine. Brain Res. 1482, 40-46. doi: 10.1016/j.brainres.2012.09.001
211. Kitanaka, J., Kitanaka, N., Tatsuta, T., Hall, F. S., Uhl, G. R., Tanaka, K., et al. (2009). Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice. Psychopharmacology (Berl.) 203, 781-792. doi: 10.1007/s00213-008-1425-z
212. Kostic, M., Zivkovic, N., and Stojanovic, I. (2013). Multiple sclerosis and glutamate excitotoxicity. Rev. Neurosci. 24, 71-88. doi: 10.1515/revneuro-2012-0062
213. Kou, W., Banerjee, S., Eudy, J., Smith, L. M., Persidsky, R., Borgmann, K., et al. (2009). CD38 regulation in activated astrocytes: implications for neuroinflammation and HIV-1 brain infection. J. Neurosci. Res. 87, 2326-2339. doi: 10.1002/jnr.22060
214. Krasnova, I. N., and Cadet, J. L. (2009). Methamphetamine toxicity and messengers of death. Brain Res. Rev. 60, 379-407. doi: 10.1016/j.brainresrev.2009.03.002
215. Kutsch, O., Oh, J., Nath, A., and Benveniste, E. N. (2000). Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74, 9214-9221. doi: 10.1128/JVI.74.19.9214-9221.2000
216. Ladeby, R., Wirenfeldt, M., Garcia-Ovejero, D., Fenger, C., Dissing-Olesen, L., Dalmau, I., et al. (2005). Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev. 48, 196-206. doi: 10.1016/j.brainresrev.2004.12.009
217. Lane, H. Y., Lin, C. H., Green, M. F., Hellemann, G., Huang, C. C., Chen, P. W., et al. (2013). Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. JAMA Psychiatry 70, 1267-1275. doi: 10.1001/jamapsychiatry.2013.2159
218. Langford, D., Grigorian, A., Hurford, R., Adame, A., Crews, L., and Masliah, E. (2004). The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J. Neurovirol. 10, 327-337. doi: 10.1080/13550280490520961
219. Langford, D., and Masliah, E. (2001). Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 11, 306-312. doi: 10.1111/j.1750-3639.2001.tb00401.x
220. Lau, J. W., Senok, S., and Stadlin, A. (2000). Methamphetamine-induced oxidative stress in cultured mouse astrocytes. Ann. N.Y. Acad. Sci. 914, 146-156. doi: 10.1111/j.1749-6632.2000.tb05192.x
221. LaVoie, M. J., and Hastings, T. G. (1999). Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19, 1484-1491.
222. Lawson, L. J., Perry, V. H., and Gordon, S. (1992). Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48, 405-415.
223. Lee, E. J., and Kim, H. S. (2014). The anti-inflammatory role of tissue inhibitor of metalloproteinase-2 in lipopolysaccharide-stimulated microglia. J. Neuroinflammation 11:116. doi: 10.1186/1742-2094-11-116
224. Lee, S. C., Liu, W., Dickson, D. W., Brosnan, C. F., and Berman, J. W. (1993). Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150, 2659-2667.
225. Lewis, W. (2003). Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions. Antiviral Res. 58, 189-197. doi: 10.1016/S0166-3542(03)00069-X
226. Li, G. H., Anderson, C., Jaeger, L., Do, T., Major, E. O., and Nath, A. (2015). Cell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4. AIDS 29, 755-766. doi: 10.1097/QAD.0000000000000605
227. Li, T., Giaume, C., and Xiao, L. (2014). Connexins-mediated glia networking impacts myelination and remyelination in the central nervous system. Mol. Neurobiol. 49, 1460-1471. doi: 10.1007/s12035-013-8625-1
228. Li, W., Henderson, L. J., Major, E. O., and Al-Harthi, L. (2011). IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner. J. Immunol. 186, 6771-6778. doi: 10.4049/jimmunol.1100099
229. Liang, H., Wang, X., Chen, H., Song, L., Ye, L., Wang, S. H., et al. (2008). Methamphetamine enhances HIV infection of macrophages. Am. J. Pathol. 172, 1617-1624. doi: 10.2353/ajpath.2008.070971
230. Lindemann, L., Meyer, C. A., Jeanneau, K., Bradaia, A., Ozmen, L., Bluethmann, H., et al. (2008). Trace amine-associated receptor 1 modulates dopaminergic activity. J. Pharmacol. Exp. Ther. 324, 948-956. doi: 10.1124/jpet.107.132647
231. Linder, M., and Gagel, C. (1968). [Virus infection and blood coagulation]. Thromb. Diath. Haemorrh. 20, 603-604.
232. Liu, W., Shafit-Zagardo, B., Aquino, D. A., Zhao, M. L., Dickson, D. W., Brosnan, C. F., et al. (1994). Cytoskeletal alterations in human fetal astrocytes induced by interleukin-1 beta. J. Neurochem. 63, 1625-1634.
233. Liu, X., Shah, A., Gangwani, M. R., Silverstein, P. S., Fu, M., and Kumar, A. (2014a). HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors. Sci. Rep. 4:4450. doi: 10.1038/srep04450
234. Liu, Y., Liu, H., Kim, B. O., Gattone, V. H., Li, J., Nath, A., et al. (2004). CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J. Virol. 78, 4120-4133. doi: 10.1128/JVI.78.8.4120-4133.2004
235. Liu, Z., Shi, Z., Liu, J., and Wang, Y. (2014b). HIV transactivator of transcription enhances methamphetamine-induced Parkinson's-like behavior in the rats. Neuroreport. doi: 10.1097/WNR.0000000000000199. [Epub ahead of print].
236. Liu, Z., Zhao, F., and He, J. J. (2014c). Hepatitis C virus (HCV) interaction with astrocytes: nonproductive infection and induction of IL-18. J. Neurovirol. 20, 278-293. doi: 10.1007/s13365-014-0245-7
237. Loewinger, G. C., Beckert, M. V., Tejeda, H. A., and Cheer, J. F. (2012). Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism. Neuropharmacology 62, 2192-2201. doi: 10.1016/j.neuropharm.2012.01.013
238. Louboutin, J. P., and Strayer, D. S. (2012). Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications. ScientificWorldJournal 2012:482575. doi: 10.1100/2012/482575
239. Lu, W., Maheshwari, A., Misiuta, I., Fox, S. E., Chen, N., Zigova, T., et al. (2005). Neutrophil-specific chemokines are produced by astrocytic cells but not by neuronal cells. Brain Res. Dev. Brain Res. 155, 127-134. doi: 10.1016/j.devbrainres.2005.01.004
240. Ludwig, A., Schulte, A., Schnack, C., Hundhausen, C., Reiss, K., Brodway, N., et al. (2005). Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J. Neurochem. 93, 1293-1303. doi: 10.1111/j.1471-4159.2005.03123.x
241. Luo, X., and He, J. J. (2015). Cell-cell contact viral transfer contributes to HIV infection and persistence in astrocytes. J. Neurovirol. 21, 66-80. doi: 10.1007/s13365-014-0304-0
242. Ma, R., Yang, L., Niu, F., and Buch, S. (2014). HIV Tat-mediated induction of human brain microvascular endothelial cell apoptosis involves endoplasmic reticulum stress and mitochondrial dysfunction. Mol. Neurobiol. doi: 10.1007/s12035-014-8991-3. [Epub ahead of print].
243. Maciaszek, J. W., Parada, N. A., Cruikshank, W. W., Center, D. M., Kornfeld, H., and Viglianti, G. A. (1997). IL-16 represses HIV-1 promoter activity. J. Immunol. 158, 5-8.
244. Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Adal, A., et al. (2008). Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res. 1203, 133-148. doi: 10.1016/j.brainres.2008.01.093
245. Mamik, M. K., and Ghorpade, A. (2012). Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytes. PLoS ONE 7:e45596. doi: 10.1371/journal.pone.0045596
246. Mamik, M. K., and Ghorpade, A. (2014). Chemokine CXCL8 promotes HIV-1 replication in human monocyte-derived macrophages and primary microglia via nuclear factor-kappaB pathway. PLoS ONE 9:e92145. doi: 10.1371/journal.pone.0092145
247. Mamik, M. K., Banerjee, S., Walseth, T. F., Hirte, R., Tang, L., Borgmann, K., et al. (2011). HIV-1 and IL-1beta regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-kappaB signaling mechanisms. J. Neuroinflammation 8:145. doi: 10.1186/1742-2094-8-145
248. Manev, H., Favaron, M., Guidotti, A., and Costa, E. (1989). Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death. Mol. Pharmacol. 36, 106-112.
249. Mantri, C. K., Mantri, J. V., Pandhare, J., and Dash, C. (2014). Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression. Am. J. Pathol. 184, 92-100. doi: 10.1016/j.ajpath.2013.09.011
250. Maragos, W. F., Jakel, R., Chesnut, D., Pocernich, C. B., Butterfield, D. A., St Clair, D., et al. (2000). Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Res. 878, 218-222. doi: 10.1016/S0006-8993(00)02707-4
251. Mark, K. A., Quinton, M. S., Russek, S. J., and Yamamoto, B. K. (2007). Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. J. Neurosci. 27, 6823-6831. doi: 10.1523/JNEUROSCI.0013-07.2007
252. Martins, T., Burgoyne, T., Kenny, B. A., Hudson, N., Futter, C. E., Ambrósio, A. F., et al. (2013). Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. Neuropharmacology 65, 74-82. doi: 10.1016/j.neuropharm.2012.08.021
253. Matinella, A., Lanzafame, M., Bonometti, M. A., Gajofatto, A., Concia, E., Vento, S., et al. (2015). Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study. J. Neurol. 262, 1317-1327. doi: 10.1007/s00415-015-7713-8
254. Matsumoto, R. R., Shaikh, J., Wilson, L. L., Vedam, S., and Coop, A. (2008). Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: evidence from in vivo and in vitro studies. Eur. Neuropsychopharmacol. 18, 871-881. doi: 10.1016/j.euroneuro.2008.07.006
255. Mayo, L., Trauger, S. A., Blain, M., Nadeau, M., Patel, B., Alvarez, J. I., et al. (2014). Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20, 1147-1156. doi: 10.1038/nm.3681
256. McArthur, J. C., Brew, B. J., and Nath, A. (2005). Neurological complications of HIV infection. Lancet Neurol. 4, 543-555. doi: 10.1016/S1474-4422(05)70165-4
257. McClure, J., Lovelace, E. S., Elahi, S., Maurice, N. J., Wagoner, J., Dragavon, J., et al. (2012). Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation. PLoS ONE 7:e41832. doi: 10.1371/journal.pone.0041832
258. Mehla, R., Bivalkar-Mehla, S., Nagarkatti, M., and Chauhan, A. (2012). Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator. J. Neuroinflammation 9:239. doi: 10.1186/1742-2094-9-239
259. Mémet, S. (2006). NF-kappaB functions in the nervous system: from development to disease. Biochem. Pharmacol. 72, 1180-1195. doi: 10.1016/j.bcp.2006.09.003
260. Messam, C. A., and Major, E. O. (2000). Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J. Neurovirol. 6(Suppl. 1), S90-S94.
261. Miller, G. M. (2011). The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J. Neurochem. 116, 164-176. doi: 10.1111/j.1471-4159.2010.07109.x
262. Miller, G. M. (2012). Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1). J. Med. Chem. 55, 1809-1814. doi: 10.1021/jm201437t
263. Miyazaki, I., Asanuma, M., Kikkawa, Y., Takeshima, M., Murakami, S., Miyoshi, K., et al. (2011). Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia 59, 435-451. doi: 10.1002/glia.21112
264. Mizoguchi, H., Yamada, K., Mouri, A., Niwa, M., Mizuno, T., Noda, Y., et al. (2007a). Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release. J. Neurochem. 102, 1548-1560. doi: 10.1111/j.1471-4159.2007.04623.x
265. Mizoguchi, H., Yamada, K., and Nabeshima, T. (2008). Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and-9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents. J. Pharmacol. Sci. 106, 9-14. doi: 10.1254/jphs.FM0070139
266. Mizoguchi, H., Yamada, K., Niwa, M., Mouri, A., Mizuno, T., Noda, Y., et al. (2007b). Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and-9-deficient mice. J. Neurochem. 100, 1579-1588. doi: 10.1111/j.1471-4159.2006.04288.x
267. Mohsenzadegan, M., Fayazi, M. R., Abdolmaleki, M., Bakhshayesh, M., Seif, F., and Mousavizadeh, K. (2015). Direct immunomodulatory influence of IFN-beta on human astrocytoma cells. Immunopharmacol. Immunotoxicol. 37, 214-219. doi: 10.3109/08923973.2015.1014559
268. Mollace, V., Colasanti, M., Rodino, P., Lauro, G. M., and Nistico, G. (1994). HIV coating gp 120 glycoprotein-dependent prostaglandin E2 release by human cultured astrocytoma cells is regulated by nitric oxide formation. Biochem. Biophys. Res. Commun. 203, 87-92. doi: 10.1006/bbrc.1994.2152
269. Molteni, C. G., Principi, N., and Esposito, S. (2014). Reactive oxygen and nitrogen species during viral infections. Free Radic. Res. 48, 1163-1169. doi: 10.3109/10715762.2014.945443
270. Moore, C. S., Milner, R., Nishiyama, A., Frausto, R. F., Serwanski, D. R., Pagarigan, R. R., et al. (2011). Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J. Neurosci. 31, 6247-6254. doi: 10.1523/JNEUROSCI.5474-10.2011
271. Moszczynska, A., Fitzmaurice, P., Ang, L., Kalasinsky, K. S., Schmunk, G. A., Peretti, F. J., et al. (2004). Why is parkinsonism not a feature of human methamphetamine users? Brain 127, 363-370. doi: 10.1093/brain/awh046
272. Moynagh, P. N. (2005). The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain. J. Anat. 207, 265-269. doi: 10.1111/j.1469-7580.2005.00445.x
273. Mrak, R. E., and Griffin, W. S. (1997). The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus. J. Neurovirol. 3, 241-246.
274. Muñoz, M. F., Puebla, M., and Figueroa, X. F. (2015). Control of the neurovascular coupling by nitric oxide-dependent regulation of astrocytic Ca(2+) signaling. Front. Cell. Neurosci. 9:59. doi: 10.3389/fncel.2015.00059
275. Muscoli, C., Salvemini, D., Paolino, D., Iannone, M., Palma, E., Cufari, A., et al. (2002). Peroxynitrite decomposition catalyst prevents apoptotic cell death in a human astrocytoma cell line incubated with supernatants of HIV-infected macrophages. BMC Neurosci. 3:13. doi: 10.1186/1471-2202-3-13
276. Nader, J., Rapino, C., Gennequin, B., Chavant, F., Francheteau, M., Makriyannis, A., et al. (2014). Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. Neuropharmacology 87, 214-221. doi: 10.1016/j.neuropharm.2014.03.014
277. Nagai, T., and Yamada, K. (2010). [Molecular mechanism for methamphetamine-induced memory impairment]. Nihon Arukoru Yakubutsu Igakkai Zasshi 45, 81-91.
278. Nair, M. P., Saiyed, Z. M., Nair, N., Gandhi, N. H., Rodriguez, J. W., Boukli, N., et al. (2009). Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J. Neuroimmune Pharmacol. 4, 129-139. doi: 10.1007/s11481-008-9128-0
279. Nakamichi, K., Kitani, H., Takayama-Ito, M., Morimoto, K., Kurane, I., and Saijo, M. (2010). Celastrol suppresses morphological and transcriptional responses in microglial cells upon stimulation with double-stranded RNA. Int. J. Neurosci. 120, 252-257. doi: 10.3109/00207451003615763
280. Nanda, B. L., Nataraju, A., Rajesh, R., Rangappa, K. S., Shekar, M. A., and Vishwanath, B. S. (2007). PLA2 mediated arachidonate free radicals: PLA2 inhibition and neutralization of free radicals by anti-oxidants-a new role as anti-inflammatory molecule. Curr. Top. Med. Chem. 7, 765-777. doi: 10.2174/156802607780487623
281. Narita, M., Miyatake, M., Narita, M., Shibasaki, M., Shindo, K., Nakamura, A., Kuzumaki, N., et al. (2006). Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology 31, 2476-2488. doi: 10.1038/sj.npp.1301007
282. Navarrete, M., and Araque, A. (2008). Endocannabinoids mediate neuron-astrocyte communication. Neuron 57, 883-893. doi: 10.1016/j.neuron.2008.01.029
283. Navarrete, M., and Araque, A. (2010). Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 68, 113-126. doi: 10.1016/j.neuron.2010.08.043
284. Newman, E. A. (2015). Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 370:20140195. doi: 10.1098/rstb.2014.0195
285. Nguyen, L., Kaushal, N., Robson, M. J., and Matsumoto, R. R. (2014). Sigma receptors as potential therapeutic targets for neuroprotection. Eur. J. Pharmacol. 743, 42-47. doi: 10.1016/j.ejphar.2014.09.022
286. Nikfarjam, B. A., Ebtekar, M., Sabouni, F., Pourpak, Z., and Kheirandish, M. (2014). Detection of interleukin-19 mRNA in C57BL/6 mice astroglial cells and brain cortex. Basic Clin. Neurosci. 5, 88-95.
287. Nomura, A., Ujike, H., Tanaka, Y., Kishimoto, M., Otani, K., Morita, Y., et al. (2006). Association study of the tumor necrosis factor-alpha gene and its 1A receptor gene with methamphetamine dependence. Ann. N.Y. Acad. Sci. 1074, 116-124. doi: 10.1196/annals.1369.011
288. Nookala, A. R., and Kumar, A. (2014). Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes. J. Neuroinflammation 11, 214. doi: 10.1186/s12974-014-0214-3
289. Northrop, N. A., and Yamamoto, B. K. (2015). Methamphetamine effects on blood-brain barrier structure and function. Front. Neurosci. 9:69. doi: 10.3389/fnins.2015.00069
290. Nottet, H. S., Jett, M., Flanagan, C. R., Zhai, Q. H., Persidsky, Y., Rizzino, A., et al. (1995). A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154, 3567-3581.
291. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J. L., Arenzana-Seisdedos, F., et al. (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833-835. doi: 10.1038/382833a0
292. Okamoto, M., Wang, X., and Baba, M. (2005). HIV-1-infected macrophages induce astrogliosis by SDF-1alpha and matrix metalloproteinases. Biochem. Biophys. Res. Commun. 336, 1214-1220. doi: 10.1016/j.bbrc.2005.08.251
293. Oliveira da Cruz, J. F., Robin, L. M., Drago, F., Marsicano, G., and Metna-Laurent, M. (2015). Astroglial type-1 cannabinoid receptor (CB): a new player in the tripartite synapse. Neuroscience. doi: 10.1016/j.neuroscience.2015.05.002. [Epub ahead of print].
294. Ozdener, H. (2005). Molecular mechanisms of HIV-1 associated neurodegeneration. J. Biosci. 30, 391-405. doi: 10.1007/BF02703676
295. Pacher, P., Beckman, J. S., and Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424. doi: 10.1152/physrev.00029.2006
296. Padovani-Claudio, D. A., Liu, L., Ransohoff, R. M., and Miller, R. H. (2006). Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2. Glia 54, 471-483. doi: 10.1002/glia.20383
297. Panas, M. W., Xie, Z., Panas, H. N., Hoener, M. C., Vallender, E. J., and Miller, G. M. (2012). Trace amine associated receptor 1 signaling in activated lymphocytes. J. Neuroimmune Pharmacol. 7, 866-876. doi: 10.1007/s11481-011-9321-4
298. Pang, X., Panee, J., Liu, X., Berry, M. J., Chang, S. L., and Chang, L. (2013). Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration. J. Neuroimmune Pharmacol. 8, 691-704. doi: 10.1007/s11481-013-9454-8
299. Pang, Y., Cai, Z., and Rhodes, P. G. (2001). Analysis of genes differentially expressed in astrocytes stimulated with lipopolysaccharide using cDNA arrays. Brain Res. 914, 15-22. doi: 10.1016/S0006-8993(01)02766-4
300. Paradise, M. B., Naismith, S. L., Norrie, L. M., Graeber, M. B., and Hickie, I. B. (2012). The role of glia in late-life depression. Int. Psychogeriatr. 24, 1878-1890. doi: 10.1017/S1041610212000828
301. Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., et al. (2002). A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708. doi: 10.4049/jimmunol.168.11.5699
302. Pasqualetti, G., Brooks, D. J., and Edison, P. (2015). The role of neuroinflammation in dementias. Curr. Neurol. Neurosci. Rep. 15:17. doi: 10.1007/s11910-015-0531-7
303. Passaro, R. C., Pandhare, J., Qian, H. Z., and Dash, C. (2015). The Complex interaction between methamphetamine abuse and HIV-1 pathogenesis. J. Neuroimmune Pharmacol. 10, 477-486. doi: 10.1007/s11481-015-9604-2
304. Patapoutian, A., and Reichardt, L. F. (2001). Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 11, 272-280. doi: 10.1016/S0959-4388(00)00208-7
305. Patel, A., Vasanthan, V., Fu, W., Fahlman, R. P., MacTavish, D., and Jhamandas, J. H. (2015). Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype. Brain Struct. Funct. doi: 10.1007/s00429-015-1007-x. [Epub ahead of print].
306. Penas, C., Pascual-Font, A., Mancuso, R., Forés, J., Casas, C., and Navarro, X. (2011). Sigma receptor agonist 2-(4-morpholinethyl)1 phenylcyclohexanecarboxylate (Pre084) increases GDNF and BiP expression and promotes neuroprotection after root avulsion injury. J. Neurotrauma 28, 831-840. doi: 10.1089/neu.2010.1674
307. Peng, H., Erdmann, N., Whitney, N., Dou, H., Gorantla, S., Gendelman, H. E., et al. (2006). HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta. Glia 54, 619-629. doi: 10.1002/glia.20409
308. Peng, H., Wu, Y., Duan, Z., Ciborowski, P., and Zheng, J. C. (2012). Proteolytic processing of SDF-1alpha by matrix metalloproteinase-2 impairs CXCR4 signaling and reduces neural progenitor cell migration. Protein Cell 3, 875-882. doi: 10.1007/s13238-012-2092-8
309. Phillips, T. R., Billaud, J. N., and Henriksen, S. J. (2000). Methamphetamine and HIV-1: potential interactions and the use of the FIV/cat model. J. Psychopharmacol. 14, 244-250. doi: 10.1177/026988110001400309
310. Porter, J. T., and McCarthy, K. D. (1997). Astrocytic neurotransmitter receptors in situ and in vivo. Prog. Neurobiol. 51, 439-455.
311. Potula, R., Hawkins, B. J., Cenna, J. M., Fan, S., Dykstra, H., Ramirez, S. H., et al. (2010). Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. J. Immunol. 185, 2867-2876. doi: 10.4049/jimmunol.0903691
312. Puma, C., Danik, M., Quirion, R., Ramon, F., and Williams, S. (2001). The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 78, 960-971. doi: 10.1046/j.1471-4159.2001.00469.x
313. Qi, L., Gang, L., Hang, K. W., Ling, C. H., Xiaofeng, Z., Zhen, L., et al. (2011). Programmed neuronal cell death induced by HIV-1 tat and methamphetamine. Microsc. Res. Tech. 74, 1139-1144. doi: 10.1002/jemt.21006
314. Qin, H., and Benveniste, E. N. (2012). ELISA methodology to quantify astrocyte production of cytokines/chemokines in vitro. Methods Mol. Biol. 814, 235-249. doi: 10.1007/978-1-61779-452-0_16
315. Ramesh, G., MacLean, A. G., and Philipp, M. T. (2013). Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013:480739. doi: 10.1155/2013/480739
316. Ramirez, S. H., Potula, R., Fan, S., Eidem, T., Papugani, A., Reichenbach, N., et al. (2009). Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J. Cereb. Blood Flow Metab. 29, 1933-1945. doi: 10.1038/jcbfm.2009.112
317. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., et al. (1993). Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7, 592-600.
318. Raposo, C., and Schwartz, M. (2014). Glial scar and immune cell involvement in tissue remodeling and repair following acute CNS injuries. Glia 62, 1895-1904. doi: 10.1002/glia.22676
319. Rasooli-Nejad, S., Palygin, O., Lalo, U., and Pankratov, Y. (2014). Cannabinoid receptors contribute to astroglial Ca(2)(+)-signalling and control of synaptic plasticity in the neocortex. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369, 20140077. doi: 10.1098/rstb.2014.0077
320. Rasty, S., Thatikunta, P., Gordon, J., Khalili, K., Amini, S., and Glorioso, J. C. (1996). Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 93, 6073-6078.
321. Ravizza, T., Boer, K., Redeker, S., Spliet, W. G., Van Rijen, P. C., Troost, D., et al. (2006). The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol. Dis. 24, 128-143. doi: 10.1016/j.nbd.2006.06.003
322. Ray, P. D., Huang, B. W., and Tsuji, Y. (2012). Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24, 981-990. doi: 10.1016/j.cellsig.2012.01.008
323. Raz, L., Knoefel, J., and Bhaskar, K. (2015). The neuropathology and cerebrovascular mechanisms of dementia. J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2015.164. [Epub ahead of print].
324. Reback, C. J., Larkins, S., and Shoptaw, S. (2003). Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 15, 775-785. doi: 10.1080/09540120310001618621
325. Reddy, P. V., Gandhi, N., Samikkannu, T., Saiyed, Z., Agudelo, M., Yndart, A., et al. (2012). HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder. Neurochem. Int. 61, 807-814. doi: 10.1016/j.neuint.2011.06.011
326. Reissner, K. J., Brown, R. M., Spencer, S., Tran, P. K., Thomas, C. A., and Kalivas, P. W. (2014). Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism. Neuropsychopharmacology 39, 499-506. doi: 10.1038/npp.2013.223
327. Renner, N. A., Ivey, N. S., Redmann, R. K., Lackner, A. A., and MacLean, A. G. (2011). MCP-3/CCL7 production by astrocytes: implications for SIV neuroinvasion and AIDS encephalitis. J. Neurovirol. 17, 146-152. doi: 10.1007/s13365-010-0017-y
328. Revel, F. G., Meyer, C. A., Bradaia, A., Jeanneau, K., Calcagno, E., André, C. B., et al. (2012). Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Neuropsychopharmacology 37, 2580-2592. doi: 10.1038/npp.2012.109
329. Revel, F. G., Moreau, J. L., Gainetdinov, R. R., Bradaia, A., Sotnikova, T. D., Mory, R., et al. (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc. Natl. Acad. Sci. U.S.A. 108, 8485-8490. doi: 10.1073/pnas.1103029108
330. Revel, F. G., Moreau, J. L., Pouzet, B., Mory, R., Bradaia, A., Buchy, D., et al. (2013). A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic-and antidepressant-like activity, improve cognition and control body weight. Mol. Psychiatry 18, 543-556. doi: 10.1038/mp.2012.57
331. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J. Int. Neuropsychol. Soc. 10, 1-14. doi: 10.1017/S1355617704101021
332. Roberts, A. J., Maung, R., Sejbuk, N. E., Ake, C., and Kaul, M. (2010a). Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120. J. Neurosci. Methods 186, 222-225. doi: 10.1016/j.jneumeth.2009.11.007
333. Roberts, T. K., Eugenin, E. A., Morgello, S., Clements, J. E., Zink, M. C., and Berman, J. W. (2010b). PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am. J. Pathol. 177, 1848-1860. doi: 10.2353/ajpath.2010.091006
334. Robertson, K. R., Smurzynski, M., Parsons, T. D., Wu, K., Bosch, R. J., Wu, J., et al. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21, 1915-1921. doi: 10.1097/QAD.0b013e32828e4e27
335. Robson, M. J., Seminerio, M. J., McCurdy, C. R., Coop, A., and Matsumoto, R. R. (2013a). sigma Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Pharmacol. Rep. 65, 343-349. doi: 10.1016/S1734-1140(13)71009-0
336. Robson, M. J., Turner, R. C., Naser, Z. J., McCurdy, C. R., Huber, J. D., and Matsumoto, R. R. (2013b). SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Exp. Neurol. 247, 134-142. doi: 10.1016/j.expneurol.2013.04.009
337. Robson, M. J., Turner, R. C., Naser, Z. J., McCurdy, C. R., O'Callaghan, J. P., Huber, J. D., et al. (2014). SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Exp. Neurol. 254, 180-189. doi: 10.1016/j.expneurol.2014.01.020
338. Rock, R. B., Gekker, G., Hu, S., Sheng, W. S., Cabral, G. A., Martin, B. R., et al. (2007). WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J. Neuroimmune Pharmacol. 2, 178-183. doi: 10.1007/s11481-006-9040-4
339. Rosenthal, M. (2006). Methamphetamine use Increases Risk of Acquiring HIV, STDs and MRSA [Online]. 2006 International Conference on Emerging Infectious Diseases: Healio. Available online at: http://www.healio.com/infectious-disease/hiv-aids/news/print/infectious-disease-news/%7B458a3b28-01a8-45ca-af13-dead2d781f8b%7D/methamphetamine-use-increases-risk-of-acquiring-hiv-stds-and-mrsa (Accessed July 15, 2015).
340. Rostasy, K., Egles, C., Chauhan, A., Kneissl, M., Bahrani, P., Yiannoutsos, C., et al. (2003). SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. J. Neuropathol. Exp. Neurol. 62, 617-626.
341. Roth, A. D., Ramírez, G., Alarcón, R., and Von Bernhardi, R. (2005). Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation. Biol. Res. 38, 381-387. doi: 10.4067/S0716-97602005000400011
342. Rusyniak, D. E. (2013). Neurologic manifestations of chronic methamphetamine abuse. Psychiatr. Clin. North Am. 36, 261-275. doi: 10.1016/j.psc.2013.02.005
343. Ryan, L. A., Peng, H., Erichsen, D. A., Huang, Y., Persidsky, Y., Zhou, Y., et al. (2004). TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia. J. Neuroimmunol. 148, 127-139. doi: 10.1016/j.jneuroim.2003.11.019
344. Sabri, F., Titanji, K., De Milito, A., and Chiodi, F. (2003). Astrocyte activation and apoptosis: their roles in the neuropathology of HIV infection. Brain Pathol. 13, 84-94. doi: 10.1111/j.1750-3639.2003.tb00009.x
345. Saha, R. N., Liu, X., and Pahan, K. (2006). Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine. J. Neuroimmune Pharmacol. 1, 212-222. doi: 10.1007/s11481-006-9020-8
346. Saikali, P., Antel, J. P., Pittet, C. L., Newcombe, J., and Arbour, N. (2010). Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. J. Immunol. 185, 5693-5703. doi: 10.4049/jimmunol.1002188
347. Salamanca, S. A., Sorrentino, E. E., Nosanchuk, J. D., and Martinez, L. R. (2014). Impact of methamphetamine on infection and immunity. Front. Neurosci. 8:445. doi: 10.3389/fnins.2014.00445
348. Salisbury, D., and Bronas, U. (2015). Reactive oxygen and nitrogen species: impact on endothelial dysfunction. Nurs. Res. 64, 53-66. doi: 10.1097/NNR.0000000000000068
349. Salmaggi, A., Gelati, M., Dufour, A., Corsini, E., Pagano, S., Baccalini, R., et al. (2002). Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J. Interferon Cytokine Res. 22, 631-640. doi: 10.1089/10799900260100114
350. Samikkannu, T., Agudelo, M., Gandhi, N., Reddy, P. V., Saiyed, Z. M., Nwankwo, D., et al. (2011). Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: implications for neuroAIDS. J. Neurovirol. 17, 230-238. doi: 10.1007/s13365-011-0026-5
351. Samikkannu, T., Rao, K. V., Kanthikeel, S. P., Atluri, V. S., Agudelo, M., Roy, U., et al. (2014). Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification. Free Radic. Biol. Med. 69, 136-144. doi: 10.1016/j.freeradbiomed.2013.12.025
352. Samikkannu, T., Rao, K. V., Salam, A. A., Atluri, V. S., Kaftanovskaya, E. M., Agudelo, M., et al. (2015). HIV Subtypes B and C gp120 and methamphetamine interaction: dopaminergic system implicates differential neuronal toxicity. Sci. Rep. 5:11130. doi: 10.1038/srep11130
353. Sbai, O., Ould-Yahoui, A., Ferhat, L., Gueye, Y., Bernard, A., Charrat, E., et al. (2010). Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia 58, 344-366. doi: 10.1002/glia.20927
354. Schiavon, A. P., Soares, L. M., Bonato, J. M., Milani, H., Guimarães, F. S., and Weffort De Oliveira, R. M. (2014). Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. Neurotox. Res. 26, 307-316. doi: 10.1007/s12640-014-9457-0
355. Schulz, J. B., Matthews, R. T., Klockgether, T., Dichgans, J., and Beal, M. F. (1997). The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol. Cell. Biochem. 174, 193-197.
356. Seminerio, M. J., Robson, M. J., McCurdy, C. R., and Matsumoto, R. R. (2012). Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1beta mRNA expression in the hypothalamus. Eur. J. Pharmacol. 691, 103-109. doi: 10.1016/j.ejphar.2012.07.029
357. Shah, A., Kumar, S., Simon, S. D., Singh, D. P., and Kumar, A. (2013). HIV gp120-and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1. Cell Death Dis. 4, e850. doi: 10.1038/cddis.2013.374
358. Shah, A., Silverstein, P. S., Kumar, S., Singh, D. P., and Kumar, A. (2012a). Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes. PLoS ONE 7:e52060. doi: 10.1371/journal.pone.0052060
359. Shah, A., Silverstein, P. S., Singh, D. P., and Kumar, A. (2012b). Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-kappaB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes. J. Neuroinflammation 9:52. doi: 10.1186/1742-2094-9-52
360. Shah, A., Verma, A. S., Patel, K. H., Noel, R., Rivera-Amill, V., Silverstein, P. S., et al. (2011). HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoS ONE 6:e21261. doi: 10.1371/journal.pone.0021261
361. Sharma, A., Hu, X. T., Napier, T. C., and Al-Harthi, L. (2011). Methamphetamine and HIV-1 Tat down regulate beta-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity. J. NeuroImmune Pharmacol. 6, 597-607. doi: 10.1007/s11481-011-9295-2
362. Sheng, W. S., Hu, S., Min, X., Cabral, G. A., Lokensgard, J. R., and Peterson, P. K. (2005). Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia 49, 211-219. doi: 10.1002/glia.20108
363. Sherbourne, C. D., Hays, R. D., Fleishman, J. A., Vitiello, B., Magruder, K. M., Bing, E. G., et al. (2000). Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am. J. Psychiatry 157, 248-254. doi: 10.1176/appi.ajp.157.2.248
364. Shi, B., Raina, J., Lorenzo, A., Busciglio, J., and Gabuzda, D. (1998). Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4, 281-290.
365. Shin, J. H., Park, Y. M., Kim, D. H., Moon, G. J., Bang, O. Y., Ohn, T., et al. (2014). Ischemic brain extract increases SDF-1 expression in astrocytes through the CXCR2/miR-223/miR-27b pathway. Biochim. Biophys. Acta 1839, 826-836. doi: 10.1016/j.bbagrm.2014.06.019
366. Shrikant, P., Benos, D. J., Tang, L. P., and Benveniste, E. N. (1996). HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. involvement of janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J. Immunol. 156, 1307-1314.
367. Silva, C. D., Neves, A. F., Dias, A. I., Freitas, H. J., Mendes, S. M., Pita, I., et al. (2014). A single neurotoxic dose of methamphetamine induces a long-lasting depressive-like behaviour in mice. Neurotox. Res. 25, 295-304. doi: 10.1007/s12640-013-9423-2
368. Simões, P. F., Silva, A. P., Pereira, F. C., Marques, E., Milhazes, N., Borges, F., et al. (2008). Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex. Ann. N.Y. Acad. Sci. 1139, 232-241. doi: 10.1196/annals.1432.028
369. Singh, G., and Pai, R. S. (2015). Dawn of antioxidants and immune modulators to stop HIV-progression and boost the immune system in HIV/AIDS patients: An updated comprehensive and critical review. Pharmacol. Rep. 67, 600-605. doi: 10.1016/j.pharep.2014.12.007
370. Skuljec, J., Gudi, V., Ulrich, R., Frichert, K., Yildiz, O., Pul, R., et al. (2011). Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter. J. Neuropathol. Exp. Neurol. 70, 758-769. doi: 10.1097/NEN.0b013e3182294fad
371. Smith, K. J., Butler, T. R., and Prendergast, M. A. (2010). Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and-naive hippocampi. Neurosci. Lett. 481, 144-148. doi: 10.1016/j.neulet.2010.06.069
372. Smits, H. A., Rijsmus, A., van Loon, J. H., Wat, J. W., Verhoef, J., Boven, L. A., et al. (2002). Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes. J. Neuroimmunol. 127, 160-168. doi: 10.1016/S0165-5728(02)00112-1
373. Speth, C., Joebstl, B., Barcova, M., and Dierich, M. P. (2000). HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones. AIDS 14, 629-636. doi: 10.1097/00002030-200004140-00001
374. Speth, C., Schabetsberger, T., Mohsenipour, I., Stöckl, G., Würzner, R., Stoiber, H., et al. (2002). Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J. Virol. 76, 3179-3188. doi: 10.1128/JVI.76.7.3179-3188.2002
375. Speth, C., Stöckl, G., Mohsenipour, I., Würzner, R., Stoiber, H., Lass-Flörl, C., et al. (2001). Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes. J. Virol. 75, 2604-2615. doi: 10.1128/JVI.75.6.2604-2516.2001
376. Stall, R., Paul, J. P., Greenwood, G., Pollack, L. M., Bein, E., Crosby, G. M., et al. (2001). Alcohol use, drug use and alcohol-related problems among men who have sex with men: the urban men's health study. Addiction 96, 1589-1601. doi: 10.1080/09652140120080723
377. Stanika, R. I., Pivovarova, N. B., Brantner, C. A., Watts, C. A., Winters, C. A., and Andrews, S. B. (2009). Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc. Natl. Acad. Sci. U.S.A. 106, 9854-9859. doi: 10.1073/pnas.0903546106
378. Stavrovskaya, I. G., and Kristal, B. S. (2005). The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death? Free Radic. Biol. Med. 38, 687-697. doi: 10.1016/j.freeradbiomed.2004.11.032
379. Strack, A., Asensio, V. C., Campbell, I. L., Schluter, D., and Deckert, M. (2002). Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathol. 103, 458-468. doi: 10.1007/s00401-001-0491-7
380. Strazza, M., Pirrone, V., Wigdahl, B., and Nonnemacher, M. R. (2011). Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res. 1399, 96-115. doi: 10.1016/j.brainres.2011.05.015
381. Streit, W. J. (2000). Microglial response to brain injury: a brief synopsis. Toxicol. Pathol. 28, 28-30. doi: 10.1177/019262330002800104
382. Sturdevant, C. B., Joseph, S. B., Schnell, G., Price, R. W., Swanstrom, R., and Spudich, S. (2015). Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog. 11:e1004720. doi: 10.1371/journal.ppat.1004720
383. Su, Z. Z., Leszczyniecka, M., Kang, D. C., Sarkar, D., Chao, W., Volsky, D. J., et al. (2003). Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2). Proc. Natl. Acad. Sci. U.S.A. 100, 1955-1960. doi: 10.1073/pnas.0136555100
384. Sundaram, M., Saghayam, S., Priya, B., Venkatesh, K. K., Balakrishnan, P., Shankar, E. M., et al. (2008). Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India. Int. J. Infect. Dis. 12, e61-e66. doi: 10.1016/j.ijid.2008.04.004
385. Suryadevara, R., Holter, S., Borgmann, K., Persidsky, R., Labenz-Zink, C., Persidsky, Y., et al. (2003). Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: Links to HIV-1 dementia. Glia 44, 47-56. doi: 10.1002/glia.10266
386. Sweitzer, S., and De Leo, J. (2011). Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. Handb. Exp. Pharmacol. 200, 235-250. doi: 10.1007/978-3-642-13443-2_8
387. Takahashi, K., Foster, J. B., and Lin, C. L. (2015). Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease. Cell. Mol. Life Sci. 72, 3489-3506. doi: 10.1007/s00018-015-1937-8
388. Tatro, E. T., Soontornniyomkij, B., Letendre, S. L., and Achim, C. L. (2014). Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir. BMC Infect. Dis. 14:386. doi: 10.1186/1471-2334-14-386
389. Tavazzi, E., Morrison, D., Sullivan, P., Morgello, S., and Fischer, T. (2014). Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr. HIV Res. 12, 97-110. doi: 10.2174/1570162X12666140526114956
390. Tawfik, V. L., Lacroix-Fralish, M. L., Bercury, K. K., Nutile-McMenemy, N., Harris, B. T., and Deleo, J. A. (2006). Induction of astrocyte differentiation by propentofylline increases glutamate transporter expression in vitro: heterogeneity of the quiescent phenotype. Glia 54, 193-203. doi: 10.1002/glia.20365
391. Thatikunta, P., Sawaya, B. E., Denisova, L., Cole, C., Yusibova, G., Johnson, E. M., et al. (1997). Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells. J. Cell. Biochem. 67, 466-477.
392. Theodore, S., Cass, W. A., and Maragos, W. F. (2006a). Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum. Exp. Neurol. 199, 490-498. doi: 10.1016/j.expneurol.2006.01.009
393. Theodore, S., Stolberg, S., Cass, W. A., and Maragos, W. F. (2006b). Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Ann. N.Y. Acad. Sci. 1074, 178-190. doi: 10.1196/annals.1369.018
394. Tong, J., Fitzmaurice, P., Furukawa, Y., Schmunk, G. A., Wickham, D. J., Ang, L. C., et al. (2014). Is brain gliosis a characteristic of chronic methamphetamine use in the human? Neurobiol. Dis. 67, 107-118. doi: 10.1016/j.nbd.2014.03.015
395. Torre, D., Pugliese, A., and Speranza, F. (2002). Role of nitric oxide in HIV-1 infection: friend or foe? Lancet Infect. Dis. 2, 273-280. doi: 10.1016/S1473-3099(02)00262-1
396. Tousi, N. S., Buck, D. J., Curtis, J. T., and Davis, R. L. (2012). Alpha-synuclein potentiates interleukin-1beta-induced CXCL10 expression in human A172 astrocytoma cells. Neurosci. Lett. 507, 133-136. doi: 10.1016/j.neulet.2011.12.001
397. Trifilo, M. J., and Lane, T. E. (2003). Adenovirus-mediated expression of CXCL10 in the central nervous system results in T-cell recruitment and limited neuropathology. J. Neurovirol. 9, 315-324. doi: 10.1080/13550280390201029
398. Tufekci, K. U., Meuwissen, R., Genc, S., and Genc, K. (2012). Inflammation in Parkinson's disease. Adv. Protein Chem. Struct. Biol. 88, 69-132. doi: 10.1016/B978-0-12-398314-5.00004-0
399. Urrutia, A., Granado, N., Gutierrez-Lopez, M. D., Moratalla, R., O'shea, E., and Colado, M. I. (2014). The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum. Int. J. Neuropsychopharmacol. 17, 235-246. doi: 10.1017/S1461145713000850
400. Uzasci, L., Nath, A., and Cotter, R. (2013). Oxidative stress and the HIV-infected brain proteome. J. Neuroimmune Pharmacol. 8, 1167-1180. doi: 10.1007/s11481-013-9444-x
401. Valcour, V., and Shiramizu, B. (2004). HIV-associated dementia, mitochondrial dysfunction, and oxidative stress. Mitochondrion 4, 119-129. doi: 10.1016/j.mito.2004.05.009
402. Van der Meide, P. H., and Schellekens, H. (1996). Cytokines and the immune response. Biotherapy 8, 243-249.
403. van Marle, G., Henry, S., Todoruk, T., Sullivan, A., Silva, C., Rourke, S. B., et al. (2004). Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329, 302-318. doi: 10.1016/j.virol.2004.08.024
404. Vartak-Sharma, N., Gelman, B. B., Joshi, C., Borgamann, K., and Ghorpade, A. (2014). Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-kappaB signaling and excitatory amino acid transporter-2 repression. J. Biol. Chem. 289, 19599-19612. doi: 10.1074/jbc.M114.567644
405. Vazquez, C., Tolon, R. M., Pazos, M. R., Moreno, M., Koester, E. C., Cravatt, B. F., et al. (2015). Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: in vivo studies. Neurobiol. Dis. 79, 41-50. doi: 10.1016/j.nbd.2015.04.005
406. Vázquez-Santiago, F. J., Noel, R. J. Jr., Porter, J. T., and Rivera-Amill, V. (2014). Glutamate metabolism and HIV-associated neurocognitive disorders. J. Neurovirol. 20, 315-331. doi: 10.1007/s13365-014-0258-2
407. Vergote, D., Butler, G. S., Ooms, M., Cox, J. H., Silva, C., Hollenberg, M. D., et al. (2006). Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 103, 19182-19187. doi: 10.1073/pnas.0604678103
408. Verkhratskii, A. N., and Butt, A. (2013). Glial Physiology and Pathophysiology. Chichester; Hoboken, NJ: Wiley-Blackwell.
409. Viviani, B., Corsini, E., Galli, C. L., and Marinovich, M. (1998). Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol. Appl. Pharmacol. 150, 271-276.
410. Vivithanaporn, P., Maingat, F., Lin, L. T., Na, H., Richardson, C. D., Agrawal, B., et al. (2010). Hepatitis C virus core protein induces neuroimmune activation and potentiates human immunodeficiency virus-1 neurotoxicity. PLoS ONE 5:e12856. doi: 10.1371/journal.pone.0012856
411. Voskuhl, R. R., Peterson, R. S., Song, B., Ao, Y., Morales, L. B., Tiwari-Woodruff, S., et al. (2009). Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 29, 11511-11522. doi: 10.1523/JNEUROSCI.1514-09.2009
412. Wahl, S. M., Allen, J. B., McCartney-Francis, N., Morganti-Kossmann, M. C., Kossmann, T., Ellingsworth, L., et al. (1991). Macrophage-and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med. 173, 981-991.
413. Wang, X., Wang, Y., Ye, L., Li, J., Zhou, Y., Sakarcan, S., et al. (2012). Modulation of intracellular restriction factors contributes to methamphetamine-mediated enhancement of acquired immune deficiency syndrome virus infection of macrophages. Curr. HIV Res. 10, 407-414. doi: 10.2174/157016212802138797
414. Wang, Z., Pekarskaya, O., Bencheikh, M., Chao, W., Gelbard, H. A., Ghorpade, A., et al. (2003). Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 312, 60-73. doi: 10.1016/S0042-6822(03)00181-8
415. Wang, Z., Trillo-Pazos, G., Kim, S. Y., Canki, M., Morgello, S., Sharer, L. R., et al. (2004). Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J. Neurovirol. 10(Suppl. 1), 25-32. doi: 10.1080/753312749
416. Waschbisch, A., Fiebich, B. L., Akundi, R. S., Schmitz, M. L., Hoozemans, J. J., Candelario-Jalil, E., et al. (2006). Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB. J. Neurochem. 96, 680-693. doi: 10.1111/j.1471-4159.2005.03599.x
417. Weinstein, J. D., Gonzalez, E. R., Egleton, R. D., and Hunt, D. A. (2013). A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol. Consult. pharm. 28, 443-454. doi: 10.4140/TCP.n.2013.443
418. Weissberg, I., Wood, L., Kamintsky, L., Vazquez, O., Milikovsky, D. Z., Alexander, A., et al. (2015). Albumin induces excitatory synaptogenesis through astrocytic TGF-beta/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction. Neurobiol. Dis. 78, 115-125. doi: 10.1016/j.nbd.2015.02.029
419. Welser-Alves, J. V., Crocker, S. J., and Milner, R. (2011). A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli. J. Neuroinflammation 8:61. doi: 10.1186/1742-2094-8-61
420. Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., et al. (2015). Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313, 2456-2473. doi: 10.1001/jama.2015.6358
421. Wires, E. S., Alvarez, D., Dobrowolski, C., Wang, Y., Morales, M., Karn, J., et al. (2012). Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells. J. Neurovirol. 18, 400-410. doi: 10.1007/s13365-012-0103-4
422. Witwer, K. W., Gama, L., Li, M., Bartizal, C. M., Queen, S. E., Varrone, J. J., et al. (2009). Coordinated regulation of SIV replication and immune responses in the CNS. PLoS ONE 4:e8129. doi: 10.1371/journal.pone.0008129
423. Wolinsky, T. D., Swanson, C. J., Smith, K. E., Zhong, H., Borowsky, B., Seeman, P., et al. (2007). The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav. 6, 628-639. doi: 10.1111/j.1601-183X.2006.00292.x
424. Woollard, S. M., Bhargavan, B., Yu, F., and Kanmogne, G. D. (2014). Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 34, 1047-1059. doi: 10.1038/jcbfm.2014.54
425. Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., and Holdcroft, A. (2005). Cannabis use in HIV for pain and other medical symptoms. J. Pain Symptom Manage 29, 358-367. doi: 10.1016/j.jpainsymman.2004.07.011
426. Wu, Q., Miller, R. H., Ransohoff, R. M., Robinson, S., Bu, J., and Nishiyama, A. (2000). Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J. Neurosci. 20, 2609-2617.
427. Wynn, T. A. (2003). IL-13 effector functions. Annu. Rev. Immunol. 21, 425-456. doi: 10.1146/annurev.immunol.21.120601.141142
428. Wyss-Coray, T., Feng, L., Masliah, E., Ruppe, M. D., Lee, H. S., Toggas, S. M., et al. (1995). Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am. J. Pathol. 147, 53-67.
429. Xia, M., Qin, S., McNamara, M., Mackay, C., and Hyman, B. T. (1997). Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am. J. Pathol. 150, 1267-1274.
430. Xing, H. Q., Hayakawa, H., Gelpi, E., Kubota, R., Budka, H., and Izumo, S. (2009). Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. J. Neuropathol. Exp. Neurol. 68, 199-209. doi: 10.1097/NEN.0b013e31819715df
431. Xu, R., El-Hage, N., and Dever, S. M. (2015). Fluorescently-labeled RNA packaging into HIV-1 particles: direct examination of infectivity across central nervous system cell types. J. Virol. Methods 224, 20-29. doi: 10.1016/j.jviromet.2015.07.023
432. Yang, C. M., Hsieh, H. L., Yu, P. H., Lin, C. C., and Liu, S. W. (2015). IL-1beta Induces MMP-9-dependent brain astrocytic migration via transactivation of PDGF receptor/NADPH oxidase 2-derived reactive oxygen species signals. Mol. Neurobiol. 52, 303-317. doi: 10.1007/s12035-014-8838-y
433. Yoshida, H., Imaizumi, T., Fujimoto, K., Matsuo, N., Kimura, K., Cui, X., et al. (2001). Synergistic stimulation, by tumor necrosis factor-alpha and interferon-gamma, of fractalkine expression in human astrocytes. Neurosci. Lett. 303, 132-136. doi: 10.1016/S0304-3940(01)01699-8
434. Youn, G. S., Kwon, D. J., Ju, S. M., Rhim, H., Bae, Y. S., Choi, S. Y., et al. (2014). Celastrol ameliorates HIV-1 Tat-induced inflammatory responses via NF-kappaB and AP-1 inhibition and heme oxygenase-1 induction in astrocytes. Toxicol. Appl. Pharmacol. 280, 42-52. doi: 10.1016/j.taap.2014.07.010
435. Yu, A. C., Liu, R. Y., Zhang, Y., Sun, H. R., Qin, L. Y., Lau, L. T., et al. (2007). Glial cell line-derived neurotrophic factor protects astrocytes from staurosporine-and ischemia-induced apoptosis. J. Neurosci. Res. 85, 3457-3464. doi: 10.1002/jnr.21345
436. Zaritsky, L. A., Gama, L., and Clements, J. E. (2012). Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2. J. Immunol. 188, 3876-3885. doi: 10.4049/jimmunol.1103024
437. Zhang, L., Zhao, W., Li, B., Alkon, D. L., Barker, J. L., Chang, Y. H., et al. (2000). TNF-alpha induced over-expression of GFAP is associated with MAPKs. Neuroreport 11, 409-412. doi: 10.1097/00001756-200002070-00037
438. Zhang, S., Jin, Y., Liu, X., Yang, L., Ge, Z. J., Wang, H., et al. (2014). Methamphetamine modulates glutamatergic synaptic transmission in rat primary cultured hippocampal neurons. Brain Res. 1582, 1-11. doi: 10.1016/j.brainres.2014.07.040
439. Zhang, Y., Lv, X., Bai, Y., Zhu, X., Wu, X., Chao, J., et al. (2015). Involvement of sigma-1 receptor in astrocyte activation induced by methamphetamine via up-regulation of its own expression. J. Neuroinflammation 12, 29. doi: 10.1186/s12974-015-0250-7
440. Zhang, Z., Fauser, U., and Schluesener, H. J. (2008). Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury. Neuropathol. Appl. Neurobiol. 34, 330-339. doi: 10.1111/j.1365-2990.2007.00893.x
441. Zhou, Y., Sonobe, Y., Akahori, T., Jin, S., Kawanokuchi, J., Noda, M., et al. (2011). IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J. Immunol. 186, 4415-4421. doi: 10.4049/jimmunol.1003307
442. Zhu, H., Liu, X. W., Cai, T. Y., Cao, J., Tu, C. X., Lu, W., et al. (2010). Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway. J. Pharmacol. Exp. Ther. 334, 489-499. doi: 10.1124/jpet.110.165654
443. Zou, W., Wang, Z., Liu, Y., Fan, Y., Zhou, B. Y., Yang, X. F., et al. (2010). Involvement of p300 in constitutive and HIV-1 Tat-activated expression of glial fibrillary acidic protein in astrocytes. Glia 58, 1640-1648. doi: 10.1002/glia.21038